...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Oncology >Robotic prostatectomy improves outcomes--after the potentially risky adoption phase.
【24h】

Robotic prostatectomy improves outcomes--after the potentially risky adoption phase.

机译：在可能有风险的采用阶段之后，机器人前列腺切除术可改善预后。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

I am glad to comment on position papers by Dr. Moul and by Drs. Patel and Sivaraman concerning the current status of robot-assisted laparoscopic radical prostatectomy (RALP) and open retropubic radical prostatectomy (ORP). It is interesting that two well-informed prostate cancer surgeons have such different perspectives on the relative merits-or lack of merit-of RALP. There is some validity to both sides of the question.I think the most concerning aspects of the launch of robotic surgery were in two domains. The first was its aggressive marketing by hospitals and physicians, supported by industry, who oversold the relative merits of RALP during the early-adoption phase. Dr. Moul highlights this in his article. I differ from Dr. Moul somewhat in that I think much of the enthusiasm for robotics was sincere and was based on the hope that the new technology would improve outcomes for patients.
机译：我很高兴评论Moul博士和Drs的立场文件。 Patel和Sivaraman讨论了机器人辅助腹腔镜前列腺癌根治术（RALP）和耻骨后前列腺癌根治术（ORP）的现状。有趣的是，两位消息灵通的前列腺癌外科医生对RALP的相对优缺点缺乏如此不同的看法。这个问题的两面都有一定的道理。我认为，机器人手术启动最相关的方面是两个领域。首先是受到行业支持的医院和医生的积极营销，这些行业在早期采用阶段都夸大了RALP的相对优势。摩尔博士在他的文章中强调了这一点。我与Moul博士的不同之处在于，我认为机器人技术的热情是真诚的，并且基于对新技术可以改善患者治疗效果的希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号